Skip to main content

Pa. Woman Awarded $120M in Ethicon's Defective Mesh Case

Pa. Woman Awarded $120M in Ethicon's Defective Mesh Case

Pa. Woman Awarded $120M in Ethicon's Defective Mesh Case

Introduction

On Wednesday, April 24, a Philadelphia jury awarded $120 million to a woman who claimed she suffered incontinence and chronic pain due to Ethicon Inc.'s defectively designed transvaginal mesh.

The trial involved claims filed by a Pennsylvania woman who was implanted with J&J and Ethicon’s TVT-O pelvic implant to treat her urinary stress incontinence. She complained that the negligent design of the mesh caused it to erode into the soft tissue in her pelvis and injured her vagina, she had to undergo multiple surgeries to remove broken pieces of the mesh, but some fragments still remained in her body. She alleged that the complications prevented her from having sex for the last 10 years. The trial began in September 2018 and left the jury deadlocked on whether the mesh actually caused her injuries. The retrial, which began in March, was halted for a month when an expert witness suffered a heart attack. Wednesday's verdict includes $20 million in compensatory damages and $100 million in punitive damages.

There are more than 48,000 lawsuits filed against various transvaginal mesh manufacturers over devastating injuries caused due to their faulty designs. The FDA recently ordered a halt on the sale and distribution of all transvaginal mesh in the U.S.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Talcum Powder Cancer Settlement Talks Begin Sept. 4

Categories: Talcum

Representatives of Johnson & Johnson (J&J) and attorneys for tens of thousands of plaintiffs involved in talcum powder lawsuits are scheduled to meet in September 2025 in an…

Tepezza Hearing Loss Trials Delayed Until Aug 2026

Categories: Tepezza

A series of Tepezza hearing loss lawsuits, which were expected to go before juries next year, will now be delayed. The U.S. District Judge overseeing the multidistrict…

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!